By Cures Within Reach Trials have the potential to fast-track treatment options for patients with limited therapeutic alternatives
|
By Cures Within Reach Cures Within Reach will fund 16 additional clinical trials in next two years
|
By CIMS Global CIMS Global unveils groundbreaking AI powered technology for Clinical Trials
|
By CIMS Global CIMS Global, an international leader of software and services supporting clinical trials, announces today a new approach to managing DMC (Data Monitoring Committee) activities for pharmaceutical sponsors and CRO's, the DMC-HUB.
|
By Cures Within Reach Cures Within Reach also announces its latest success story and a multi-year grant from Open Philanthropy focused on LMICs
|
By ZSX Medical, LLC ZSX Medical today announced the achievement of the first clinical uses of Zip-stitch® in its pivotal U.S. clinical trial (the "ZIMS" trial). Zip‑stitch is a novel wound closure system for use in laparoscopic hysterectomy.
|
By National Brain Tumor Society Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care
|
By Cures Within Reach Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors to fund these pivotal trials
|
 | By OncoBeta GmbH OncoBeta® GmbH, a medical device company specialised in innovative epidermal radioisotope therapies, has confirmed the phase IV international multi-centre study designed to further evaluate the Complete Response Rate of patients with non-melanoma skin...
|
By Veterinary Health Research Centers LLC Veterinary Health Research Centers Finalist for Citeline's Most Innovative Start-up Company Award
|
 | By Elixia Sam Searcy joins Elixia, a site management organization, to oversee and increase business growth.
|
